Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of $209.71 million. The enterprise value is $240.79 million.

Market Cap	209.71M
Enterprise Value	240.79M

Important Dates

The last earnings date was Monday, August 4, 2025, after market close.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 72.33 million shares outstanding. The number of shares has increased by 41.82% in one year.

Current Share Class	n/a
Shares Outstanding	72.33M
Shares Change (YoY)	+41.82%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	38.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.31
Forward PS	10.31
PB Ratio	2.16
P/TBV Ratio	2.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.94.

Current Ratio	1.38
Quick Ratio	0.53
Debt / Equity	0.94
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.80

Financial Efficiency

Return on equity (ROE) is -48.02% and return on invested capital (ROIC) is -13.26%.

Return on Equity (ROE)	-48.02%
Return on Assets (ROA)	-7.43%
Return on Invested Capital (ROIC)	-13.26%
Return on Capital Employed (ROCE)	-24.24%
Revenue Per Employee	$285,757
Profits Per Employee	-$265,752
Employee Count	222
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

In the past 12 months, Cellectis has paid $455,000 in taxes.

Income Tax	455,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.77% in the last 52 weeks. The beta is 3.06, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.06
52-Week Price Change	+36.77%
50-Day Moving Average	1.92
200-Day Moving Average	1.67
Relative Strength Index (RSI)	61.01
Average Volume (20 Days)	283,718

Short Selling Information

Short Interest	178,829
Short Previous Month	263,090
Short % of Shares Out	0.34%
Short % of Float	n/a
Short Ratio (days to cover)	0.69

Income Statement

In the last 12 months, Cellectis had revenue of $63.44 million and -$59.00 million in losses. Loss per share was -$0.60.

Revenue	63.44M
Gross Profit	63.44M
Operating Income	-45.22M
Pretax Income	-80.31M
Net Income	-59.00M
EBITDA	-33.04M
EBIT	-45.22M
Loss Per Share	-$0.60

Full Income Statement

Balance Sheet

The company has $59.81 million in cash and $90.97 million in debt, giving a net cash position of -$31.16 million or -$0.43 per share.

Cash & Cash Equivalents	59.81M
Total Debt	90.97M
Net Cash	-31.16M
Net Cash Per Share	-$0.43
Equity (Book Value)	97.11M
Book Value Per Share	1.34
Working Capital	63.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.35 million and capital expenditures -$2.03 million, giving a free cash flow of -$35.37 million.

Operating Cash Flow	-33.35M
Capital Expenditures	-2.03M
Free Cash Flow	-35.37M
FCF Per Share	-$0.49

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -71.28% and -93.00%.

Gross Margin	100.00%
Operating Margin	-71.28%
Pretax Margin	-92.28%
Profit Margin	-93.00%
EBITDA Margin	-52.08%
EBIT Margin	-71.28%
FCF Margin	n/a

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.82%
Shareholder Yield	-41.82%
Earnings Yield	-28.13%
FCF Yield	-16.87%

Analyst Forecast

The average price target for Cellectis is $4.00, which is 43.37% higher than the current price. The consensus rating is "Buy".

Price Target	$4.00
Price Target Difference	43.37%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	0.44%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.95
Piotroski F-Score	3